LA JOLLA PHARMACEUTICAL CO Comprehensive Income
LA JOLLA PHARMACEUTICAL CO reported Comprehensive Income of -$26.30 million for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-10-26.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2017-10-26
- LA JOLLA PHARMACEUTICAL CO comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2017-09-30 was -$26.30M.
- LA JOLLA PHARMACEUTICAL CO comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2017-06-30 was -$26.70M.
- LA JOLLA PHARMACEUTICAL CO comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2016-09-30 was -$21.30M.
- LA JOLLA PHARMACEUTICAL CO comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2016-06-30 was -$15.60M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month |
|---|---|---|---|
| 2017-09-30 | -$26.30M 10-Q · filed 2017-10-26 | -$53.00M derived: sum of 2 quarters · filed 2017-10-26 | -$76.30M 10-Q · filed 2017-10-26 |
| 2017-06-30 | -$26.70M 10-Q · filed 2017-07-27 | -$50.00M 10-Q · filed 2017-07-27 | |
| 2016-09-30 | -$21.30M 10-Q · filed 2017-10-26 | -$36.90M derived: sum of 2 quarters · filed 2017-10-26 | -$53.30M 10-Q · filed 2017-10-26 |
| 2016-06-30 | -$15.60M 10-Q · filed 2017-07-27 | -$32.00M 10-Q · filed 2017-07-27 |